Clinical Trial Update: Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)

View source ↗

Summary

Clinical trial update on epilepsy patients assessing quality of life and adverse effects. Sponsored by UCB Pharma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Status: COMPLETED